The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Levin Arthur A since year 2005.
The trader's CIK number is 1181556.
At the time of this reporting, Levin Arthur A is the Vice President of
Isis Pharmaceuticals Inc
(stock ticker symbol ISIS).
Stock purchases, sales, and option exercises reported by Levin Arthur A since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-04-25
ISIS
Isis Pharmaceuticals Inc
Option Exercise
6,000
5.25
31,500
2007-04-25
ISIS
Isis Pharmaceuticals Inc
Sale
6,000
10.11
60,660
2006-11-09
ISIS
Isis Pharmaceuticals Inc
Option Exercise
20,000
6.81
136,200
2006-11-09
ISIS
Isis Pharmaceuticals Inc
Sale
20,000
10.13
202,600
2006-11-13
ISIS
Isis Pharmaceuticals Inc
Option Exercise
30,000
6.81
204,300
2006-11-13
ISIS
Isis Pharmaceuticals Inc
Sale
30,000
13.36
400,800
2006-10-19
ISIS
Isis Pharmaceuticals Inc
Sale
12,424
8.98
111,570
2006-10-19
ISIS
Isis Pharmaceuticals Inc
Option Exercise
12,424
5.48
68,021
2006-10-06
ISIS
Isis Pharmaceuticals Inc
Option Exercise
10,000
5.15
51,500
2006-10-06
ISIS
Isis Pharmaceuticals Inc
Sale
10,000
7.97
79,735
2006-03-20
ISIS
Isis Pharmaceuticals Inc
Option Exercise
9,500
6.84
64,980
2006-03-21
ISIS
Isis Pharmaceuticals Inc
Option Exercise
500
6.84
3,420
2006-03-20
ISIS
Isis Pharmaceuticals Inc
Sale
9,500
9.04
85,918
2006-03-21
ISIS
Isis Pharmaceuticals Inc
Sale
500
9.04
4,517
2006-02-17
ISIS
Isis Pharmaceuticals Inc
Option Exercise
7,770
5.15
40,015
2006-02-17
ISIS
Isis Pharmaceuticals Inc
Sale
7,770
8.03
62,393
2006-02-16
ISIS
Isis Pharmaceuticals Inc
Option Exercise
3,000
5.15
15,450
2006-02-16
ISIS
Isis Pharmaceuticals Inc
Sale
3,000
7.95
23,850
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Levin Arthur A
(Vice President of Isis Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
